Alpha Genomix Laboratories

Alpha Genomix Laboratories is a molecular diagnostics company based in Peachtree Corners, Georgia, specializing in personalized medicine and pharmacogenetics. The company provides a suite of diagnostic services designed to optimize patient care by tailoring treatments based on individual genetic profiles. Their core offerings include pharmacogenetic testing for psychiatry, cardiology, pain management, and cancer drug sensitivity, as well as contract research services for the life sciences industry. Acquired by Consultative Genomics (ConGen) in 2018, Alpha Genomix continues to operate as a provider of high-complexity laboratory testing to help clinicians make informed therapeutic decisions. The company's platform integrates genetic data with clinical insights to reduce trial-and-error prescribing and improve patient outcomes. Alpha Genomix utilizes advanced technologies such as next-generation sequencing and real-time PCR to deliver evidence-based results to healthcare providers.